Reply #70: Pharmaceutical companies won't stifle this, but they are businesses, after all

[IDemo]

I'm inclined to believe that Big Pharma will extract the greatest possible profit from this neither by shelving it nor making it a permanent cure, but by engineering it to function as a 'maintenance medication'. The results of the testing on mice indicated a degree of variability on the effective timespan: "Some have remained in that state for as long as four months, with just one injection."

If it is 'determined' that the only 'safe treatment' winds up being monthly or bi-monthly injections (instead of say, yearly), profits will remain in place and patients will (mostly) be happy.